TECON(SZ:002100)2025-05-15 13:03Group 1: Business Performance - In 2024, the company's feed business sales volume increased by 0.87%, while the pig farming business saw a 7.55% increase in annual output, reaching 3.0285 million pigs [2][3] - The average selling price of pigs increased by 10.5% compared to the previous year, leading to a higher revenue share from pig farming [2][3] - The company plans to sell 2.9 million tons of feed and aims for a pig output of 3.5 to 4 million heads in 2025 [2][3] Group 2: Research and Development - The company has obtained 28 national new veterinary drug certificates, focusing on improving pig breeding quality and feed formulation [3][5] - Significant R&D achievements include the development of a gene-engineered inactivated vaccine for swine fever, which is a first in the country [5][6] - The company is committed to enhancing its competitive edge through continuous R&D investments in core business areas [3][5] Group 3: Future Growth Strategies - The company plans to expand its feed, pig farming, and agricultural product businesses, leveraging its strategic location to explore markets in Central Asia [3][4] - Future growth will also involve potential mergers and acquisitions based on market conditions [4][6] - The company aims to diversify its business by exploring related fields such as pet feed and vaccines [7][9] Group 4: Financial Goals and Market Position - The company's operational targets for 2025 include a total revenue of 21 billion yuan, with specific goals for feed production, animal vaccines, and corn storage [7][9] - The company has opened over 70 direct sales stores and counters in the northwest and north China regions [11][12] - The company is focused on improving its market value through enhanced governance and investor communication [12][13]